Deconstructing pancreatic adenocarcinoma by targeting the conductor, MYC

Isabel A. English, Rosalie C. Sears

Research output: Contribution to journalArticle

Abstract

In this issue of Cancer Discovery, Sodir and colleagues employ a pancreatic ductal adenocarcinoma mouse model with mutant KRAS and inducible MYC to demonstrate that MYC acts as a reversible driver of malignant tumor progression. Abrogation of MYC triggers rapid regression and disassembly of the ensemble tumor through both cancer cell-intrinsic and cancer cell-extrinsic mechanisms, providing a compelling rationale for therapeutic targeting of MYC.

Original languageEnglish (US)
Pages (from-to)495-497
Number of pages3
JournalCancer discovery
Volume10
Issue number4
DOIs
StatePublished - Apr 2020

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Deconstructing pancreatic adenocarcinoma by targeting the conductor, MYC'. Together they form a unique fingerprint.

  • Cite this